IP of endogenous SUMO2/3 in HEK293 cells
Ontology highlight
ABSTRACT: Aim of the experiments was to identify endogenously SUMO2/3 modified proteins in HEK293 cells. Cells were treated with dexamethasone (dex) or vehicle (etoh) and with heatshock (+43C, HS) or normal growth temperature (+37C, non-HS). Cells were induced with tetracycline to express BirA*-GR (glucocorticoid receptor) to express GR at sufficient levels to assess effect of GR activation on protein SUMOylation.
INSTRUMENT(S): LTQ Orbitrap Elite
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Cell Culture
SUBMITTER: Joanna Lempiäinen
LAB HEAD: Jorma J Palvimo
PROVIDER: PXD017714 | Pride | 2021-01-11
REPOSITORIES: Pride
ACCESS DATA